Focus on Glaucoma
Program
|
National Eye Institute |
|
|---|---|
|
THURSDAY, FEBRUARY 18TH Bldg 38A - Lister Hill Auditorium | |
| 2:30 - 3:00 pm | Registration |
| 3:00 - 3:05 pm | WELCOME ADDRESS Paul A. Sieving, M.D., Ph.D. Director, National Eye Institute (NEI), NIH |
| Evening session |
Chairperson: Neeraj Agarwal, Ph.D. Director, Glaucoma and Optic Neuropathies Program, Division of Extramural Research, National Eye Institute (NEI), NIH, Bethesda, MD |
| 3:05 - 3:35 pm | Jeffrey Goldberg, M.D., Ph.D. Assistant Professor of Ophthalmology Bascom Palmer Eye Institute University of Miami, FL Intrinsic Control of Regeneration in Retinal Ganglion Cells |
| 3:40 - 4:10 pm | Larry Benowitz, Ph.D. Professor of Surgery (Neuroscience) Harvard Medical School, Boston, MA Director, Laboratories for Neuroscience Research in Neurosurgery Children’s Hospital Boston Boston, MA Oncomodulin With Other Agents Promotes Extensive Optic Nerve Regeneration |
| 4:15 - 4:30 pm | Coffee break |
| 4:30 - 5:00 pm | Stanislav Tomarev, Ph.D. & Tom Johnson NEI, Laboratory of Molecular and Developmental Biology Molecular Mechanisms of Glaucoma Section Bethesda, MD Myocilin as a Tool to Study Glaucoma Stem Cell Transplantation for Neuroprotection in Glaucoma |
| 5:05 - 5:30 pm | Reception |
| FRIDAY, FEBRUARY 19TH Bldg 10 - Lipsett Amphitheatre |
|
| 8:30 - 9:00 | Registration & Coffee |
| 9:00 - 9:05 | WELCOME ADDRESS Paul A. Sieving, M.D., Ph.D. Director, NEI, NIH, Bethesda, MD |
| Morning Session | Chairperson: Paul A. Sieving, M.D., Ph.D. Director, NEI, NIH, Bethesda, MD |
| 9:05 - 9:35 |
KEYNOTE ADDRESS Paul Lichter, M.D. F. Bruce Fralick Professor of Ophthalmology Chair, Ophthalmology and Visual Sciences Director, University of Michigan Kellogg Eye Center Ann Arbor, MI The Enigma of Glaucoma's Holy Grail: The Promise and Problems of Research |
| 9:40 - 10:10 | Fielding Hejtmancik, M.D., Ph.D. NEI, Ophthalmic Genetics and Visual Function Branch Chief, Ophthalmic Molecular Genetics Section Bethesda, MD Genetics of Primary Open-Angle Glaucoma in the Afro-Caribbean Population of Barbados |
| 10:15 - 10:35 | Coffee break |
| 10:35 - 11:05 | Janey L. Wiggs, M.D. Ph.D. Assistant Professor of Ophthalmology Harvard Medical School Massachusetts Eye and Ear Infirmary Boston, MA The NEIGHBOR Consortium GWAS for POAG: Rationale, Study Design, and Clinical Variables |
| 11.10 - 11:40 | Jonathan L. Haines, Ph.D. Director, The Center for Human Genetics Research T.H. Morgan Professor of Human Genetics Professor of Molecular Physiology & Biophysics Chief, Division of Human Genomics Vanderbilt University Medical School Nashville TN Moving Forward: GWAS and Beyond |
| 11.45 - 12:15 | Terry Gaasterland, Ph.D. Professor of Computational Genomics Director, Scripps Genome Center Institute for Genomic Medicine University of California San Diego La Jolla, CA GWAS by Targeted Genome-Wide Sequencing in Glaucoma: Challenges, Trade-Offs, and Benefits |
| 12:20 - 1:20 | Lunch break |
| Afternoon Session | Chairperson: Stanislav Tomarev, Ph.D. NEI, Laboratory of Molecular and Developmental Biology Head, Molecular Mechanisms of Glaucoma Section Bethesda, MD |
| 1:20 - 1:50 | Robert N. Weinreb, M.D. Director, Hamilton Glaucoma Center Distinguished Professor Chief, Glaucoma Division Vice Chair, Department of Ophthalmology, University of California San Diego La Jolla, CA Uveoscleral Outflow: Learning From the Past, Lessons for the Future |
| 1.55 - 2.25 | David W Sretavan, M.D., Ph.D. Edward and Estelle Alexander Professor Depts. Ophthalmology & Physiology Vice-Chair, Ophthalmology University of California San Francisco San Francisco, CA RGC Axonal Responses in Experimental Glaucoma |
| 2:30 - 2:50 | Coffee break |
| 2:50 - 3:20 | Simon W. M. John, Ph.D. Investigator, Howard Hughes Medical Institute Senior Staff Scientist The Jackson Laboratory Bar Harbor, ME Insights to Glaucoma From Mouse Genetics |
| 3:25 - 3:55 | Tiansen Li, M.D. NEI, Neurobiology-Neurodegeneration & Repair Laboratory Chief, Retinal Cell Biology & Degeneration Section Bethesda, MD Lysyl Oxidases, Elastic Fiber Homeostasis and Pseudoexfoliation Glaucoma |
| 4:00 - 4:30 |
Don Zack, M.D., Ph.D. Professor of Ophthalmology Johns Hopkins University School of Medicine Baltimore, MD Retinal Ganglion Cell Neuroprotection: Is It a Viable Treatment Strategy for Glaucoma? |
| 4:35 - 4.45 | OVERVIEW AND CONCLUDING REMARKS Paul Sieving, M.D., Ph.D. Director, NEI, NIH, Bethesda, MD |
